Sotac Pharmaceuticals Limited (NSEI: SOTAC)
Health Care · Pharmaceuticals · IN
Rs87.40
-4.95% today · -30.1% 1Y
Sotac Pharmaceuticals Limited (NSEI: SOTAC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.12M and employs 127 people.
Over the last twelve months the share price has lost 30.1%, trading between 86.00 and 139.65.
Tweenvest scores Sotac Pharmaceuticals Limited across four factors: quality 60/100, value 65/100, growth 38/100, dividend 39/100. Its strongest factor is value.
SOTAC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.12M
- Revenue (TTM)
- $10.83M
- P/E
- 16.74
- EPS
- 5.22
- Dividend yield
- 0.23%
- Beta (5Y)
- 0.04
- 52-week high
- Rs139.65
- 52-week low
- Rs86.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.05M
- Employees
- 127
- Next earnings
- —
About Sotac Pharmaceuticals Limited
Sotac Pharmaceuticals Ltd. is an India-based company operating within the pharmaceutical industry, specializing in the manufacturing of a diverse range of pharmaceutical formulations. The company functions primarily as a Contract Development and Manufacturing Organization (CDMO) and third-party manufacturer, serving both domestic and international clients. Its product portfolio includes various finished formulations such as tablets (general, beta-lactam, coated, and uncoated), capsules (general and beta-lactam), oral liquids, dry syrups, and external preparations like nasal sprays, relief sprays, and creams. Sotac Pharmaceuticals produces pharmaceuticals across numerous therapeutic areas, including anti-diabetic, anti-psychotic, vitamin and mineral supplements, anti-cold, anti-allergic, dermatological, antacid, anti-ulcerant, anti-emetic, cardiac, anti-hypertensive, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (both IP-Lactams and Non-IP-Lactams), anti-fungal, and cephalosporin products. Beyond manufacturing, the company provides essential services to the pharmaceutical sector, including regulatory services, containment solutions, formulation development, clinical batch production, commercial scale production, and packaging. Sotac Pharmaceuticals exports to over 20 countries globally, with the United States being a significant international market, and maintains a strong presence across 14 major states in India.
- ISIN
- INE0O2D01012
- Founded
- 2014
- Listed since
- Apr 13, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.